Light restored to the ball.
Printable View
Light restored to the ball.
Come on man, tell us what you see!
Interestingly I saw a moon coming through the clouds in my tea leaves this morning, hopefully your vision will back this up or will it be a case of all Pigs fed and ready to fly.
PS I hope you didnt get that ball from the $2 shop
Pierre, if you are still planning on asking questions, I'd be interested to know what they are doing on animal probiotic research and marketing (I think they have done a trial). The market for pets is huge all around the world, and I know from my own experience that tooth decay in dogs is a costly business. Tap into the punters like me I say.
Just in from Google alerts..
http://www.nzdoctor.co.nz/un-doctore...nologies-.aspx
It requires a login to view the article
Worked for me. Just another "hail fellow well met" sort of thing, typical ministerial visit of Joyce to Blis. But it is a press release raising the profile of the company, again indicating an intention of the company to do this sort of thing presumably.
From our point of view, maybe the following: "Mr Watson said Blis continues to invest heavily in its product pipeline spending over 10% of revenue on R&D. “That figure is high by New Zealand standards but it is the science backing our products that differentiates us in the markets we operate in.”
Also " showed Mr Joyce [the] potential various Blis strains have to assist lower government health costs by reducing the reliance on antibiotics. "
This could be massive if it gets wide coverage.
That might be in breach of trading rules!
Have not sold any since investing $15,000 in the 1cent issue years ago, when SP was above that!
wow! blt worth $60,000,000 and never made a profit.
and it listed at $1 and trades now at 5cents.
good stuff!
a few more cents rise and it will overtake long term profit making and dividend paying companies.
who needs fundamentals when the power of a billion shares rises empty dreams.
all good for me ...... been waiting for over a decade to recoup my investment.
I'm a bit perplexed by this one. Either there is some insider knowledge driving the lift, punters are punting or the liquidity is so bad that the demand is pushing the price hard. It's gonna be a happy Friday or a disastrous one for many depending on which of those factors is acting.
I note the sellers are upping their price today. The 2,000,000 now at 6.4 cents. After years away I got back in for 500,000 at an average of 2.9c. It is starting to look very interesting. Even if it falls away after the 29th will stay in for ride if not increase.
Gunny
It sure feels a bit over-cooked to me. I don't think we'll be getting any bad news on Friday, but I don't think what we do get will justify a market cap of $66m.
However markets are supposed to be forward-looking so maybe punters are scrambling to get in ahead of a great year in 2017?
Back on the 8th July, BLT responded to the price enquiry that they were not in breach of the continuous disclosure rules. Since then the SP has gone up by about another 25%*. Is there one keen buyer buying into an illiquid stock or is there something else going on?
*Edit: make that about 33% after the market opening price of 5.8c
Of interest to me is the effect of Blis products on strep throat. Thing is strep throat is associated to various degrees with some widespread and sometimes lifetime-expensive conditions. Rheumatic fever is well known, but also possible associations with breast cancer, psoriasis, scarlet fever, kidney disease, tonsillitis, maybe others.
Some of those associations are well known but don't self diagnose based on my post!!
BLT is first mover, and as associations are better understood and proved it can only be good for the company.
Yeah, same here. I like to use the products of companies I invest in, where possible. Have been taking Blis on a daily basis as I am a believer in probiotics. Only started earlier this year. But I'm still waiting patiently to get strep throat, though I'd even settle for a decent cold at this stage, so I can really test the benefits of Blis. Sadly, this year I have been unable to catch anything, though half the office at work have, as well as the wife and kids......... :( (sigh) suppose I'll never know if this stuff works.......Quote:
Of interest to me is the effect of Blis products on strep throat
How frequently can the NZX issue speeding tickets? Is it time for another price enquiry?
Have you considered that taking Blis products is actually providing you with a level of immunity.... (or perhaps you were being witty!)
I've long been interested in Blis but haven't taken any. However with a couple of nasty infections that have started in the throat I'm about to start knocking them back with gay abandon...
Share price is banging along nicely now, I hope it's a good news story. I'm in these for the long haul.
Any way of getting access to the Meeting online?
Thanks,
We await your report.
The presentation will almost certainly be posted, either first thing in the morning or during/after the meeting.
Might try Buccaline for the family then. Not sure if it counts as a probiotic exactly. Lots of info online as it has been around for literally decades and many swear by it. Over the counter but pharmacist only, I think because people think it prevents colds and flu but officially it does not. Unofficially - I couldn't possibly comment.
I try.Quote:
or perhaps you were being witty!
Would like to know how it works for you though, so knock em' back with all the gay abandon you want! And keep us posted.
However, if you get progressively worse and die let us know, I may consider selling all my holdings.
Calling the experts. What is the difference between Blis k12 available in NZ and Now foods blis k12 as shown on Amazon?
Easy come easy go..
Updated Guidance Blis Technologies Limited announces an updated guidance that the company expects to achieve FY2017 trading revenues in excess of $8 million and Net Profit Before Tax in excess of $0.7 million. First quarter interim results (unaudited) support this guidance with trading revenues of $1.947 million, and EBITDA of $0.34 million and a Net Income Before Tax of $0.188 million
Let the fun begin
Gunny
Let the fun begin indeed! Since there was over 0.5m in depreciation etc last year, then 0.7 m profit is presumably at least 1.2m operating profit. That is surely meaty enough for shareholders.
Looking forward to what reports we hear from the AGM tomorrow too.
Excellent indeed. And continuing the ongoing communication with shareholders, also excellent.
Well, actually, 10 cents here we come? If a $1m profit wasn't that big a stretch on a 4 cent share price, and $1.25m operating profit is already forecast, that would be 5 cents. And that is without allowing for the future much at all.
AND an actual (unaudited) profit this quarter ALREADY. "Net Income Before Tax of $0.188 million". Profit already made.
I see two drivers now going forward firstly the long awaited start of profits and the second being the:
"internationally there is a wave of interest in what is being termed the microbiome. The microbiome refers to a relatively new area of understanding of health where communities of microbes living within human bodies can influence wider human health but which also opens up options for the microbiome to be managed through the delivery of healthy bacteria (probiotics)." and this in relation to the wave of issues with the use of antibiotics.
Gunny
Gunny
There had been about a 70% increase in the SP in July until the drop back today, prior to the after hours update. The market was anticipating some very good news...
Before you get too excited, have a look at BLT chart history. There is always a big jump around every announcement date, and this time they actually were expected to announce an actual profit figure.
The big news for me, and I just did not expect it, is the idea that the share price is already potentially underpriced for the already existing profit - depending on what maths you use obviously. It will be fun watching what the market does with that.
My opinion is the share price was already too high on excitement leading up to annual meeting.
Based on the information released the firm is on track to do as they say they will, which is always a good sign.
Profit expected, but no dividend.
My value based on revenue of of past $5.6 Million and forecast in excess of $8 million
At $8 million = 42.85% growth would give me 3 cents per share
At $8.5 million = 51.78% would give me 4 cents per share
At $9 million = 60.71% would give me 5.4 cents per share
*I won't consider higher for if they were to expect higher than 9 million they would have probably said it.
Even on my high valuation at most I get is 5.4 cents, but I think its closer to 4 cents on a fair value basis for now, of course others will have higher valuations than me and thats fine. I am a much conservative investor and I never like to be too optimistic on ideal prospects when it comes to growth companies without a good track record.
Yes, but you have to figure other things in. Such as the revenue growth recently. We don't know if it will continue, but you can't ignore it surely.
And now 8m plus - and already on that figure in Q1 according to that release.
Also the fact that the company is engaging in a lot more publicity. It has been upbeat for a bit now, including the planned release of an investment research paper, new regular (?) shareholder updates, rebranding of packaging, and ads on TV again, and that must have a cumulative effect on the share price?
Also the fact that the NZX has done some pretty exciting stuff with PEs on growth companies over the years.
I don't know what the market will do. But surely there is room for interesting developments?
As far as I can see, the previous time that the NZX issued a Share Price Enquiry letter to BLT was in January 2013. In the BLT letter of explanation to that enquiry, they said that BLIS had given shareholders three months notice of its intention to enforce a minimum shareholding of 25,000 shares.
The 8 million in revenue was already known from the April 14th announcement and the share price jumped 10% and pretty much stayed there until recently....
The forecast profit is a bit ahead of where I thought it might be, so the structural changes made in 2015 have seemed to help.
I think the current share price is slightly overheated but if you believe this puppy will continue at upwards of 100% growth it's probably a steal.
Going from a loss last year of 816k to an expected profit this year of 700k (1500k turnaround) on an increase in revenue of 2500k must have taken iron willpower on costs. That's a good sign surely.
Hi Simla it's a very good sign a lot better then I expected.
first quarter finished and more then 100% up on last years same period sales a great start to the year, especially when you factor in that 80% of their sales is now off shore and most of those countries are in their summer season. Wait until the northern hemisphere winter hits. My prediction $10m in sales. Something else in the pipeline with hints of other forms of shareholder funding. At least this period of the journey is more fun then it has been over the years.
looks like the good news caught up late
Traders will care what the price is today. But for long term holders this is more likely to be an inflexion point. There will be the time before the first profit, and the time after.
BLT probably faces a bit of a mathematical wall anyway presently. Long term holders have seen a pretty decent price rise, but that makes it difficult for us to significantly change our holdings now, the relative cost being quite high now. So BLT needs to attract the next generation. Turnover has been pretty steep lately so that may have started, but it is still small compared to the number of shares on offer.
And also, attracting attention with a profit and a share price rise is merely the start. The market even then needs to start trying to figure out what BLT represents. It is a very different stock, after all.
We'll see.
Or to put it another way, New Zealanders SHOULD know how to deal with biotech given the nature of our country, but the reality is that most are much happier with number 8 fencing wire and owning homes, borrowing for farms and houses. There is always much talk of "value added" in New Zealand, but actually it is usually the foreigners who are the ones coming here and creating it.
So I'll have a tiny go. Others can throw in their ideas maybe.
Biotech is just a word. It is like dairy, or forestry, or retail, or hospitality. It is just a name for an industry. All industries sell products that other people want to buy, whether it is milk or wood or legal services or probiotics in this case. Biotech just means the product has come from some sort of scientific research on biology, whether genes or bacteria or animals or plants. It tends to need patent protection, which costs money.
The reason that people are scared of biotech - or so I think anyway - is that it is a relatively new industry so there are still a whole lot of new companies that have yet to turn a profit.
This is like the dotcom bubble of the nineties, or so I think people remember anyway. But actually an awful lot of the dotcom companies were just jumping on the bandwagon selling little more than a website address and asking huge prices from backers. They went broke because nobody ever needed the web site addresses in the first place and investors were not being very savvy about that. Biotech requires an actual product to start with, on the other hand.
But while people remember dotcom as a disaster, the truth is that some very major companies have come out of it. Amazon. Google. Alibaba. Trademe. Other industries have had to adapt to dotcom, like television, movies and newspapers, to name just a few. It was not a fly-by-night industry even though some of the companies did turn out to be that. Investors who looked hard and learnt did pretty well alongside the many others who did not.
So that dotcom industry has matured and people now understand that you have to pick and choose and use your judgement. Then you have to decide what business model to follow. Trademe runs a good profit and is a stable company paying good dividends. Xero is playing the big-hit game and willing to sink money getting there in the hope of a big payoff. Etc. Which model do shareholders personally feel comfortable backing? Coming in on the startup or joining in later if it succeeds?
In the biotech industry, a few companies have succeeded. A2 Milk is surely a biotech and for a long time people had to back it getting there, but now it has paid off, selling a product that consumers accept has health benefits. Botry Zen was another startup from Dunedin protecting kiwifruit and grapes from mould. It was a listed company but shareholders did not back it enough and it went private in 2010, where it seems to be doing just fine. Pacific Edge is biotech and seems to have good products protecting people from cancer, but the market got a bit carrried away perhaps on the share price before it had much revenue to talk of, which maybe left people a bit battered, but not PEB's fault. Each company is different and needs thinking about for each investor to understand, like any investment.
BLT is a biotech, selling probiotics protecting people from infection and bad breath and tooth decay, or so I see it. The details are on the website blis.co.nz . I guess you might also see it, less threateningly, as being in the health sector, which it is.
It is just a company selling a product. It can be read about, thought about.
I never recommend anyone buy or sell or hold BLT. That is for people to think about themselves. But I do recommend that people learn more broadly about the ideas of the biotech industry. People who walked away from dotcom because they did not understand it did not actually achieve much. Dotcom was here to stay and so is biotech. It at least deserves a little thought?
When do we stop thinking? I'm a long-term somewhat sceptical observer. Surely Blis should attempt to point to any benefits (if there are any) they have compared to what seems to be a zillion other probiotic products available marketed under recognized brand names. IOW is there a unique selling point?
Yes. Blis works. Oodles of research to that effect. Also it is the only one aimed at the throat as far as I am aware.
You raise a good point because the industry is also suffering from a lack of accepted standards. The word "probiotics" is regarded as selling point without the need to substantiate a lot.
One of Blis's burdens is indeed to differentiate itself from the market in this respect, as consumers don;t really seem to have wondered about that small point on the whole. The company has remarked over the years that its business partners have signed up because they can indeed see the difference.
But every health product has this problem doesn't it? Some are proven, some are just there.
Another 2.6m share through today. At the least, it has been an interesting time for the BLT share.
Ever hear of Yakult? I was sure surprised when I saw this being sold in the supermarkets here. Growing up in Japan we used to have the Yakult ladies cycle through the neighborhood calling out "yakult, yakult", selling it from bags. It's a probiotic for the gut, developed 80 yrs ago, sold as a little bottle of sweetened fermented milk. They have science to back up their claims, but other research has poured doubt on these. Science still seems inconclusive, but millions buy the story. Heck they sell it in NZ now! Annual worldwide group sales well north of $3billion USD these days.
Now don't go claiming the Ghost is saying that Blis will ever come close to anything like that. I'm not. Does Blis work? There are some positive results coming through for sure, but I don't think anything so conclusive as to put this firmly in the 'definitely works' category. But if enough people try it and feel it works for them, well, could be an interesting future as I think you're right in pointing out that they are the only ones with a probiotic for the mouth. If they get a decent foothold in East Asia, that could be a gamechanger for them. Probiotics much bigger there than in the west, though they are gaining ground here slowly too.
Does anyone have a contact number to call Blis or email them.
I have a friend who works in a health shop, with several branches, I always ask how the Honey Blis Lozenges are selling.
They have none left in stock, the number they used to ring doesn't exist anymore, I hope this is an isolated incident, and not indicative of their entire distribution process.
support@blis.co.nz Blis have recently taken over the honeyblis, so I imagine the old phone service has been discontinued?
As to Pierre, obviously he decided that he may as well climb Mt Cook while he was down south, doing it in blizzard conditions at night in order to just show what real men do.That's the sort of people Blis investors are. :)
I have been using blis throat guard and m18 as our family probiotics for almost 3 years now. BLT was still 2 ish cents. Really like the product, never ever had a sore throat, if so we would increase the intake n sore throat would despair. Gum and teeth are much healthier. I never interested invest in it really...I don't why, I did the research before n thier forecast n revenue never excited me really. It got my attention when they want to break Asia market,then I asked myself....would people in Asia can afford this probiotic? Instead, I bought in SEA, then sold for small profit and changed it to BFC Ozzie.
Yakut is no one in Asia. It is cheaper and affordable. It does the same functions with Blis. Blis is lozenges, yakult is liquid.
you can get yakult in Asian stores, mainly in Auckland or big cities....or similar products Pam's probiotic in pak n save. Both are similar products.5-6 small bottles of 100ml in 1 pack for around $4-5. Sometimes, pak n save discounted to $2
in Asia yakult costs around 8-10 cents each bottle. Recommended one bottle for daily intake..same with Blis. Blis lozenges cost 50c each...60 lozenges for $30. I always buy in 4, shipping free..sometimes 6...to get 10% discount.
i like blis, as I can afford it. I don't compromise when come to our family health. When we got yakult or pam one, we only drink that. Not both unless u really need it.
Anyway, conclusion: I really like blis. Thier probiotic really helps my family n me! It really works. It is quite expansive, but what matter is it really helps people who need it. I think BLT will do well in the future. Hope it helps u guys for those investing in. The challenges of BLT are to convince European population and developed countries about the benefits of thier products.
I dont hold BLT and don't have plan to buy in as I am broke...just bought couple weeks ago in NZM for dividend yield. Should bought BLT eh:D but no regret as my NZM is currently at 15% green..plus report is due soon with good dividend:t_up:
good luck guys....hope it helps.
Blizzard on the mountain may delay report, hope he has his pills.
FP, couple of research links to start http://blis.co.nz/research-studies http://www.nekta.com/#!probiotic-oral-care-1/y2pio
Maybe the Blis site should have a graphic at the top "It really works, here's the proof" linking to a much more english discussion page?
What's this - posted the other day on nzx
https://www.nzx.com/files/attachments/240298.pdf
Apologies for the delay - I only returned home an hour ago. I didn't get to Mount Cook but it was so cold in Dunedin I might as well have been on the mountain anyway. Those southerners are a hardy lot - saw several of them in the Octagon in shorts and t-shirts while I was bundled up in jacket, scarf and gloves.
I will complete my report and post it later tomorrow. Meantime - be assured that I found the meeting positive in tone and outlook and feel extremely confident that we're backing a winner. I spoke with several other shareholders who feel the same way.
I'm definitely not selling a single share and will buy more if the SP shows any sign of weakness over the coming months.
We will just assume that you use the word Octagon as a typically modest understatement for Mt Cook. I'm not actually that surprised that tough Mainlanders climb Mt Cook in just shorts and t-shirts. Impressive.
Yep, the southerlies does keep you northies away.....
I really should have walked the talk and bought a parcel of this 9 months ago....
The following is my take on the BLT AGM last Friday. Hope you find it interesting and reassuring.
The AGM was attended by about 50 shareholders.
At the start of the meeting a vote of thanks to Barry Richardson, (who attended the meeting in the audience) for his stewardship of the company and in particular for his skill at capital raising,was proposed by the chairman and passed with acclamation.
The chairman and CEO then basically reiterated the details released to the NZX the night before the meeting with most information being given by CEO Brian Watson during his presentation. Naturally, they were both upbeat about reporting a projected profit for theyear and Brian paid tribute to the work of Barry and the team for the company’s current position.
A few days prior to the event I emailed a list of questions about the company’s results and activities to Brian Watson. A number of the questions in my email were answered in last Thursday evening’s announcements. These included the quantum of the forecast FY17 profit, the first quarter sales and profit announcement, an outline of the vision for the company’s future and the direction in which product developmentis heading. Also, the matter of future capital requirements was addressed in the announcements but only to the extent that the board is reviewing the issue and no decision has been taken yet.
Brian advised that since joining the business in mid-February he had visited the company’s key markets and principal customers. He said he now has a good understanding of what the company is aboutand is optimistic about its prospects for the future.
He said last year’s product quality issue wasresolved to the satisfaction of the parties concerned and that the company has learnt plenty from the experience. As a consequence, key appointments have beenmade in the areas of quality assurance, product development and processimprovement. He also referred to last year’s appointment of a CFO – clearlythere are now sufficient beans coming in to count to justify that role!
The GRAS approval has resulted in heightened interest in Blis products from markets in Europe and Japan and this augurs well for the future. The company is reviewing its own manufacturingfacilities and those that are outsourced to ensure they can maintain growth and product quality. Fonterra was revealed as one of BLT’s outsourced manufacturers.
Overall, I felt Brian spoke very well and presented the company’s position and its prospects clearly and enthusiastically. He appears to be a very capable and confident leader and I believe he will be the right man to take the business to the next level.
At the conclusion of the formal part of the meeting thechairman sought questions from the floor. I asked a couple and also spoke toBrian Watson personally after the meeting.
CHINA: Asked about slow progress in China the chairman advised that the regulatory environment in that country hadchanged about four times in the past few years making it difficult to penetratethe market. Trials are ongoing and the company is expecting that anannouncement regarding China will be made in the last quarter of this year.
KEY RISKS:
I asked the chairman whether the Board hasidentified any key risks to the business such as competition in the market. Hereplied that the company maintains a risk register containing around 15 items that are reported on by management at each board meeting. Two principal areasthat are monitored particularly carefully are competition and regulatory risks.
He advised that competition is appearing from three companies in particular (he gave their names but unfortunately I wasn’t quick enough to record them). He said despite that, BLT is well placed to capitalise on its position and to prosper in the market.
Director Bevan Wallace also spoke to theissue of regulatory risk and said that this was the area that mostly contributed to the chairman staying awake at night. BLT needs to maintain awareness of not only the claims they make about their products but also those made by distributors and resellers. Also packaging and labelling of shipments for export are areas that need constant attention.
PRODUCT FOCUS:
Brian sees prospects for accelerated growththrough branded consumer products as the best and most profitable way forward butwithout limiting sales in other areas. Categorisation of the company’s productsis an issue in the pharmacy trade e.g. they are not cough & cold products – so hewould ultimately like to be able to market a range of Blis products in the same way as Thompsons or Blackmores do with their ranges.
TV ADS:
These will continue running through to the end of August to capitalise on the winter trade.
CLINICAL TRIALS:
The Porirua trial sponsored by the NZ Health Research Council is completed but the results cannot be shared untilt hey are published by the HRC.
SHARE CONSOLIDATION:
The company is aware of the negative "penny dreadful" perceptioncaused by the high volume of issued shares and the relatively low SP.Consolidating the shares would cost the company an NZX fee in the order of $30,000. The board feels there are better uses of company funds at present though the matter is not off the radar.
The company is commissioning an independent research report on BLT that will be released to the market when completed.
MARKETING/WEB SITE:
Brian said that a major makeover is planned for the company’s web site – including the Investor pages. He said that heintends to continue direct marketing of the company’s products online as wellas selling through pharmacies.
BLT IS AN EXPORTER:
80% of sales are from exports and this percentage will increase over time as existing markets are expanded and newones developed.
Attendees received a "goody" bag containing Blis products and were treated to an exceptional variety of finger food following the meeting. I ate your share!
SUMMARY:
Despite profits being forecast there is no prospect of dividends in the foreseeable future. In my view, I think further capital raising could well be a possibility but this would be a good thing if it is to develop facilities to bring more production in-house and to undertake more market expansion.
The business is being steadied with production capability and process improvement developed so there is a sound base from which growth can be accelerated over coming years.
Plenty of potential exists in current markets and new ones will be sought. Product development and innovation will continue with a focus on branded finished consumer goods (obviously where the margins are).
Overall, my perception is life is looking pretty good for BLT and itspatient shareholders.
Bonne chance to holders
Pierre
Thank you very much indeed for that, Pierre.
A few comments. Yes, I have seen others saying how hard it is to get into China because everything is always changing, not just BLT. Also, I note we have not been told of any plans for GRAS or supermarket level goods. Also, we have had some reference to the future, but nothing terribly specific at all, and no mention of anything in relation to 2017 which is only a few months away now.
Basically we have learnt in the last week that Blis is very upbeat and that they are now running a bottom line profit. But expectations for the future remain very vague - to me anyway.
However, all very good. It will be interesting to watch the market reaction over the next few months given that the next half report is only 3 or 4 months away.
......YES MANY THANKS FOR YOUR EFFORTS in attending on our behalf PIERRE and hope you enjoyed our share of the "goodies". Well summarized also and I take from your comments a generally positive vibe now hangs over the company.......great to hear. Im interested to hear that IN FACT we do have some competition in this select field.........I was of the impression we had it all to ourselves and were protected under specific patents.....is this NOT the case? Of course competition is not necessarily a bad thing and in fact could be taken as good news given the increased awareness it brings to ORAL PROBIOTICS (some here apparantly still dont get the point of difference with general probiotics)
Nice report Pierre. Thanks a lot.
It's important to read what I've written in conjunction with the CEO presentation released to the NZX on Thursday evening. They are building capability this year to position BLT for sustainable profitable growth.
They achieved growth across all markets in FY16 and are expecting to achieve more growth this year and in the future through branded finished goods.
They have told us they expect to achieve sales for FY17 in excess of $8m and profits of $700k+. I'm sure both of those forecasts will be relatively conservative so they can report an "out perform" result.
At the meeting they raised the spectre of competition as a risk to the business - but don't appear to be fazed by it. Nevertheless it would be a sound reason for not revealing too much detail about future plans.
The half year report in November will be interesting - and hopefully may contain some news about progress in China. More patience required!
Meantime the business has now traded profitably for two consecutive quarters and more to come. All good news compared with what we have had over the past years.
Yes, there is certainly a frisson of excitement in the air now. It's a whole new chapter.
Thanks for the report pierre, nice work. :)
Thanks Pierre for that comprehensive summary on the meeting. although only a small shareholding, I am hoping that my BLT interests will keep me happy in my retirement. What are the chances of a comvita shareprice for Blis in the next 10 years I wonder :) Maybe even dividends by then. I live in hope!
Hi Suse
Anything is possible - but some things are not very likely - though a share consolidation of 100:1 would quickly get you half way there!
I'm pretty confident things will continue to go well for BLT and if they do, we could easily expect the current SP to double or even treble over the next 2-4 years. I'm hoping it will anyway as that would keep me extremely happy in retirement.
certainly doesn't change mine either, the above company only does oral care probiotics, so only competes with Blis M18 (oral care), not K18. However, I had thought Blis was the only company targeting the mouth with probiotics, but I suppose it makes sense with the growth in this field that other companies would enter the fray. Something to keep an eye on.
But I'd also like to thank Pierre for his report! Good stuff.
Since BLT announced a maiden profit I have started to take an interest. Does anyone have a quick ball park figure for the number of shares on issue.
For the record I use Throatguard and Travelguard and have found them to be effective.
.........had a bit of a scratch around in regard this "competition" we apparantly have. To cut to the chase, I can't find any REAL competition for Blis so I remain of the opinion that we have it pretty much to ourselves AND the world is our oyster, so to speak. There is an outfit in the States that trades under the name ProBiora that's pushing their product as an oral Pro-Biotic (containing Streptococcus Oralis, S. Uberis and S.Rattus.....none of which I believe our Professor Tagg bothered with). They seem to be laying claim to only cosmetic benefits eg Teeth whitening and breath freshening and no real health benefits like BLIS eg Gum infection/decay, throat infection, teeth decay,ear infection, colds, upper respiratory infection, sinus issues, haliotosis, Rheumatic Fever? Breast Cancer?...... They also lay claim to being GRAS certified but turns out this is "Self-Affirmed" which can only be applied to cosmetic or structure-function claims. So in essence I can't see any threat to BLIS when it comes to WORLD DOMINATION in regard TRUE ORAL PROBIOTICS. If someone can correct me in this regard Im all ears (and throat of course)
Thanks for looking into that Gr8day.
I must say it is remarkably satisfying knowing that Blis is running a bottom line profit each and every day now. It really is a game changer.
I've obtained from BLT the names of the potential competitors that the chairman mentioned at the AGM. They are:
Oragenics
BioGaia
Lallemand
I haven't time to research them at the moment - hope someone else will have an opportunity to dig for some information.
A bientot
Pierre
Thanks Pierre, the more info the better. Great to get a feel of the mood.
As history repeats we leave the high SP after the good news and meander along, on low volume till the next news. It's remarkable how few shares, % wise have been traded over the last 6 weeks.
Staving brave.
pat
Hi Fp,
Confirmation of a genuine turn around ,prospects, and Shareholders who paid from $2 to less than a cent a share: with this background and the news I expected more share would be traded, wrong obviously.
What news in the future will result in trading of multi millions a day?
Pat
I suspect that many BLT holders will only sell when they feel that the prospect of future SP gains is less than it is at this time.
With a very real prospect of further above market average growth and profits (even dividends) ahead of them.... why should SP holders sell now?
I think the growth rate of revenue must be of major interest to the company now. And shareholders obviously.
A revenue growth next year of even 50% would make a big bottom line difference considering the current gross margin - depending on how much they wanted to spend on the future though. And 50% revenue growth is not unusual from the last few years. Does not mean it will happen of course.
Which in turn would make a good difference in cash position and in share price for any capital raising, if any.
So next year's growth rate could be of major impact on the company now. But these things don't just happen on calendar year ends. They will be experiencing growth now, whether strong or not strong, and that will continue all year. Will we learn more in the November report in 3 months? But they will presumably give us an update in February or March anyway, still only 6 or 7 months away. We must at least hear the 6 months revenue in November.
Strong growth now would leave the share price looking cheap, I would have thought. Mediocre growth would leave it still just ticking over though, and let's not think too hard about the possibility of bad news!
The company said it was asking for an independent research paper. I wonder when that will come out. It is hard to see how they could do that without specifically discussing the whole growth thing. Will they dare recommend a price, I wonder, given how volatile the situation still is?
It promises to be a pretty exciting 6 months for shareholders and the company alike. Good news could be quite a kick forward, and mediocre news not. So there is quite a range of possible results in just the next 6 months or so.
BLT reminds me somewhat of ATM {A2 Milk} many years ago. I looked at it when it was 4 cents with many shares on issue. It started to show promise and the SP rose. Then there was a [from memory] 50 to 1 share consolidation.
So if you had 100 shares at 4 cents that is $4.0 in your portfolio. Then after a 50 to 1 consolidation you would have 2 shares at $2.0 for the same $4.0 in your portfolio. And that is about where the SP is at today. If anyone has followed ATM closely over the last 20 years they might like to comment.
Discl: not holding but interested in the product.
Good support; has someone a sniff of the contents of the research report?